Associations between Pregnane X Receptor and Breast Cancer Growth and Progression
Abstract
:1. Introduction
2. PXR and Breast Cancer
2.1. PXR and the Cell Cycle
2.2. PXR and Chemotherapeutic Resistance
2.3. PXR and Metastasis and Angiogenesis
2.4. PXR and the Inflammatory Immune Response
2.5. Role of PXR Polymorphisims
3. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Staudinger, J.L. Clinical applications of small molecule inhibitors of Pregnane X receptor. Mol. Cell. Endocrinol. 2019, 485, 61–71. [Google Scholar] [CrossRef] [PubMed]
- Xing, Y.; Yan, J.; Niu, Y. PXR: A center of transcriptional regulation in cancer. Acta Pharm. Sin. B 2020, 10, 197. [Google Scholar] [CrossRef] [PubMed]
- Petryszak, R.; Keays, M.; Tang, Y.A.; Fonseca, N.A.; Barrera, E.; Burdett, T.; Fullgrabe, A.; Fuentes, A.M.-P.; Jupp, S.; Koskinen, S.; et al. Expression Atlas update—An integrated database of gene and protein expression in humans, animals and plants. Nucleic Acids Res. 2016, 44, D746–D752. [Google Scholar] [CrossRef] [PubMed]
- Bertilsson, G.; Heidrich, J.; Svensson, K.; Asman, M.; Jendeberg, L.; Sydow-Backman, M.; Ohlsson, R.; Postlind, H.; Blomquist, P.; Berkenstam, A. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc. Natl. Acad. Sci. USA 1998, 95, 12208–12213. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kliewer, S.A.; Moore, J.T.; Wade, L.; Staudinger, J.L.; Watson, M.A.; Jones, S.A.; McKee, D.D.; Oliver, B.B.; Willson, T.M.; Zetterstrom, R.H.; et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998, 92, 73–82. [Google Scholar] [CrossRef] [Green Version]
- Lehmann, J.M.; McKee, D.D.; Watson, M.A.; Willson, T.M.; Moore, J.T.; Kliewer, S.A. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Investig. 1998, 102, 1016–1023. [Google Scholar] [CrossRef] [PubMed]
- Staudinger, J.L.; Goodwin, B.; Jones, S.A.; Hawkins-Brown, D.; MacKenzie, K.I.; LaTour, A.; Liu, Y.; Klaassen, C.D.; Brown, K.K.; Reinhard, J.; et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. USA 2001, 98, 3369–3374. [Google Scholar] [CrossRef] [Green Version]
- Goodwin, B.; Moore, L.B.; Stoltz, C.M.; McKee, D.D.; Kliewer, S.A. Regulation of the Human CYP2B6 Gene by the Nuclear Pregnane X Receptor. Mol. Pharmacol. 2001, 60, 427–431. [Google Scholar]
- Desai, P.B.; Nallani, S.C.; Sane, R.S.; Moore, L.B.; Goodwin, B.J.; Buckley, D.J.; Buckley, A.R. Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen. Drug Metab. Dispos. 2002, 30, 608–612. [Google Scholar] [CrossRef] [Green Version]
- Synold, T.W.; Dussault, I.; Forman, B.M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat. Med. 2001, 7, 584–590. [Google Scholar] [CrossRef]
- Harmsen, S.; Maijerman, I.; Febus, C.L.; Maas-Bakker, R.F.; Beijnen, J.H.; Schellens, J.H. PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line. Cancer Chemother. Pharmacol. 2010, 66, 765–771. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lamb, D.C.; Waterman, M.R.; Kelly, S.L.; Guenferich, F.P. Cytochromes P450 and drug discovery. Curr. Opin. Biotechnol. 2007, 18, 504–512. [Google Scholar] [CrossRef] [PubMed]
- Mani, S.; Huang, H.; Sundarababu, S.; Liu, W.; Kalpana, G.; Smith, A.B.; Horwitz, S.B. Activation of the steroid and xenobiotic receptor (human pregnane X receptor) by nontaxane microtubule-stabilizing agents. Clin. Cancer Res. 2005, 11, 6359–6369. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, H.; Venkatesh, M.; Li, H.; Goetz, R.; Mukherjee, S.; Biswas, A.; Zhu, L.; Kaubisch, A.; Wang, L.; Pullman, J.; et al. Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. J. Clin. Investig. 2011, 121, 3220–3232. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhou, J.; Liu, M.; Zhai, Y.; Xie, W. The antiapoptotic role of pregnane X receptor in human colon cancer cells. Mol. Endocrinol. 2008, 22, 868–880. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zucchini, N.; de Sousa, G.; Bailly-Maitre, B.; Gugenheim, J.; Bars, R.; Lemaire, G.; Rahmani, R. Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes. Biochim. Biophys. Acta 2005, 1745. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Saradhi, M.; Sengupta, A.; Mukhopadhyay, G.; Tyagi, R.K. Pregnane and Xenobiotic Receptor (PXR/SXR) resides predominantly in the nuclear compartment of the interphase cell and associates with the condensed chromosomes during mitosis. Biochim. Biophys. Acta 2005, 1746, 85–94. [Google Scholar] [CrossRef] [Green Version]
- Masuyama, H.; Nakatsukasa, H.; Takamoto, N.; Hiramatsu, Y. Down-Regulation of Pregnane X Receptor Contributes to Cell Growth Inhibition and Apoptosis by Anticancer Agents in Endometrial Cancer Cells. Mol. Pharmacol. 2007, 72, 1045–1053. [Google Scholar] [CrossRef]
- Pondugula, S.R.; Mani, S. Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response. Cancer Lett. 2013, 328, 1–9. [Google Scholar] [CrossRef] [Green Version]
- Maeda, T.; Oyabu, M.; Yotsumoto, T.; Higashi, R.; Nagata, K.; Yamazoe, Y.; Tamai, I. Effect of pregnane X receptor ligand on pharmacokinetics of substrates of organic cation transporter Oct1 in rats. Drug Metab. Dispos. 2007, 35. [Google Scholar] [CrossRef] [Green Version]
- Cho, S.K.; Yoon, J.S.; Lee, M.G.; Lee, D.H.; Lim, L.A.; Park, K.; Park, M.S.; Chung, J.-Y. Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants. Clin. Pharmacol. Ther. 2011, 89, 416–421. [Google Scholar] [CrossRef] [PubMed]
- Staudinger, J.L.; Madan, A.; Carol, K.M.; Parkinson, A. Regulation of drug transporter gene expression by nuclear receptors. Drug Metab. Dispos. 2003, 31, 523–527. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kast, H.R.; Goodwin, B.; Tarr, P.T.; Jones, S.A.; Anisfeld, A.M.; Stoltz, C.M.; Tontonoz, P.; Kliewer, S.A.; Willson, T.M.; Edwards, P.A. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 2002, 277, 2908–2915. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Staudinger, J.L.; Woody, S.K.; Sun, M.; Cui, W. Nuclear-receptor-mediated regulation of drug- and bile-acid-transporter proteins in gut and liver. Drug Metab. Rev. 2013, 45, 48–59. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Geick, A.; Eichelbaum, M.; Burk, O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. 2001, 276, 14581–14587. [Google Scholar] [CrossRef] [Green Version]
- Burk, O.; Arnold, K.A.; Nussler, A.K.; Schaeffeler, E.; Efimova, E.; Avery, B.A.; Avery, M.A.; Fromm, M.F.; Eichelbaum, M. Antimalarial Artemisinin Drugs Induce Cytochrome P450 and MDR1 Expression by Activation of Xenosensors Pregnane X Receptor and Constitutive Androstane Receptor. Mol. Pharmacol. 2005, 67, 1954–1965. [Google Scholar] [CrossRef] [Green Version]
- Pondugula, S.R.; Dong, H.; Chen, T. Phosphorylation and protein–protein interactions in PXR-mediated CYP3A repression. Expert Opin. Drug Metab. Toxicol. 2009, 5, 861–873. [Google Scholar] [CrossRef] [Green Version]
- Pavek, P. Pregnane X Receptor (PXR)-Mediated Gene Repression and Cross-Talk of PXR with Other Nuclear Receptors via Coactivator Interactions. Front. Pharmacol. 2016, 7. [Google Scholar] [CrossRef] [Green Version]
- Takezawa, T.; Matsunaga, T.; Aikawa, K.; Nakamura, K.; Ohmori, S. Lower expression of HNF4α and PGC1α might impair rifampicin-mediated CYP3A4 induction under conditions where PXR is overexpressed in human fetal liver cells. Drug Metab. Pharmacokinet. 2012, 27, 430–438. [Google Scholar] [CrossRef] [Green Version]
- Sharma, D.; Lau, A.J.; Sherman, M.A.; Chang, T.K.H. Agonism of human pregnane X receptor by rilpivirine and etravirine: Comparison with first generation non-nucleoside reverse transcriptase inhibitors. Biochem. Pharmacol. 2013, 85, 1700–1711. [Google Scholar] [CrossRef]
- Conde, I.; Lobo, M.V.; Zamora, J.; Perez, J.; Gonzalez, F.J.; Alba, E.; Fraile, B.; Paniagua, R.; Arenas, M.I. Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha. BMC Cancer 2008, 8, 174. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yue, X.; Akahira, J.-I.; Utsunomiya, H.; Miki, Y.; Takahashi, N.; Niikura, H.; Ito, K.; Sasano, H.; Okamura, K.; Yaegashi, N. Steroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer. Pathol. Int. 2010, 60, 400–406. [Google Scholar] [CrossRef] [PubMed]
- Planque, C.; Rajabi, F.; Grillet, F.; Finetti, P.; Bertucci, F.; Gironella, M.; Lozano, J.J.; Beucher, B.; Giraud, J.; Grarambois, V.; et al. Pregnane X-receptor promotes stem cell-mediated colon cancer relapse. Oncotarget 2016, 7, 56558–56573. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gupta, D.; Venkatesh, M.; Wang, H.; Kim, S.; Sinz, M.; Goldberg, G.L.; Whitney, K.; Longley, C.; Mani, S. Expanding the roles for pregnane X receptor in cancer: Proliferation and drug resistance in ovarian cancer. Clin. Cancer Res. 2008, 14, 5332–5340. [Google Scholar] [CrossRef] [Green Version]
- Jiang, Y.; Feng, D.; Ma, X.; Fan, S.; Gao, Y.; Fu, K.; Wang, Y.; Sun, J.; Yao, X.; Liu, C.; et al. Pregnane X Receptor Regulates Liver Size and Liver Cell Fate by Yes-Associated Protein Activation in Mice. Hepatology 2019, 69, 343–358. [Google Scholar] [CrossRef] [Green Version]
- Chen, Y.; Tang, Y.; Chen, S.; Nie, D. Regulation of drug resistance by human pregnane X receptor in breast cancer. Cancer Biol. Ther. 2009, 8, 1265–1272. [Google Scholar] [CrossRef] [Green Version]
- Dotzlaw, H.; Leygue, E.; Watson, P.; Murphy, L.C. The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin. Cancer Res. 1999, 5, 2103–2107. [Google Scholar] [PubMed]
- zu Schwabedissen, H.E.M.; Tirona, R.G.; Yip, C.S.; Ho, R.H.; Kim, R.B. Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res. 2008, 68, 9338–9347. [Google Scholar] [CrossRef] [Green Version]
- Miki, Y.; Suzuki, T.; Kitada, K.; Yabuki, N.; Shibuya, R.; Moriya, T.; Ishida, T.; Ohuchi, N.; Blumberg, B.; Sasano, H. Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma. Cancer Res. 2006, 66, 535–542. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shizu, R.; Benoki, S.; Numakura, Y.; Kodama, S.; Miyata, M.; Yamazoe, Y.; Yoshinari, K. Xenobiotic-induced hepatocyte proliferation associated with constitutive active/androstane receptor (CAR) or peroxisome proliferator-activated receptor a (PPARa) is enhanced by pregnane X receptor (PXR) activation in mice. PLoS ONE 2013, 8, e61802. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Robbins, D.; Bakke, J.; Cherian, M.T.; Wu, J.; Chen, T. PXR interaction with p53: A meeting of two masters. Cell Death Dis. 2016, 7, e2218. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pondugula, S.R.; Pavek, P.; Mani, S. Pregnane X Receptor and Cancer: Context-Specificity is Key. Nucl. Recept. Res. 2016, 3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Verma, S.; Tabb, M.M.; Blumberg, B. Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells. BMC Cancer 2009, 9, 3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chen, T. Overcoming drug resistance by regulating nuclear receptors. Adv. Drug Deliv. Rev. 2010, 62, 1257–1264. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Campa, D.; Butterbach, K.; Slager, S.L.; Skibola, C.F.; De Sanjose, S.; Benavente, Y.; Becker, N.; Foretova, L.; Maynadie, M.; Cocco, P.; et al. A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk. Int. J. Cancer 2012, 131, 803–812. [Google Scholar] [CrossRef] [Green Version]
- Li, T.; Kong, A.-N.T.; Ma, Z.; Liu, H.; Liu, P.; Xiao, Y.; Jiang, X.; Wang, L. Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant. Oncotarget 2016, 7, 20236–20248. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Qiao, E.Q.; Yang, H.J. Effect of pregnane X receptor expression on drug resistance in breast cancer. Oncol. Lett. 2014, 7, 1191–1196. [Google Scholar] [CrossRef] [Green Version]
- Revathidevi, S.; Sudesh, R.; Vaishnavi, V.; Kaliyanasundaram, M.; MaryHelen, K.G.; Sukanya, G.; Munirajan, A.K. Screening for the 3’UTR Polymorphism of the PXR Gene in South Indian Breast Cancer Patients and its Potential Role in Pharmacogenomics. Asian Pac. J. Cancer Prev. 2016, 17, 3971–3977. [Google Scholar]
- Nabekura, T.; Kawaski, T.; Jimura, M.; Mizuno, K.; Uwai, Y. Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein. Biochem. Biophys. Rep. 2020, 21, 100727. [Google Scholar] [CrossRef]
- Mellor, H.R.; Callaghan, R. Resistance to chemotherapy in cancer: A complex and integrated cellular response. Pharmacology 2008, 81, 275–300. [Google Scholar] [CrossRef]
- Yuan, J.-H.; Cheng, J.-Q.; Ke, Y.-B.; Ji, N.-N.; Zhou, J.-M.; Zhou, L.; Huang, H.-Y.; Yang, L.-Q.; Liu, J.-J.; Xu, X.-Y.; et al. Study on the relationship between breast cancer resistance protein expression and 5-fluorouracil resistance. Zhonghua Yu Fang Yi Xue Za Zhi 2008, 42, 506–510. [Google Scholar] [PubMed]
- Bahagyaraj, E.; Ahuja, N.; Kumar, S.; Tiwari, D.; Gupta, S.; Nanduri, R.; Gupta, P. TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR. Cell Cycle 2013, 18, 3589–3602. [Google Scholar] [CrossRef] [PubMed]
- Kodama, S.; Negishi, M. Pregnane X receptor PXR activates the GADD45- beta gene, eliciting the p38 MAPK signal and cell migration. J. Biol. Chem. 2011, 286, 3570–3578. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kodama, S.; Yamazaki, Y.; Negishi, M. Pregnane X receptor represses HNF4a gene to induce insulin-like growth factor-binding protein IGFBP1 that alters morphology of and migrates HepG2 cells. Mol. Pharmacol. 2015, 88, 746–757. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Oladimeji, P.O.; Chen, T. PXR: More Than Just a Master Xenobiotic Receptor. Mol. Pharmacol. 2018, 93, 119–127. [Google Scholar] [CrossRef] [PubMed]
- Bakin, A.V.; Rinehart, C.; Tomlinson, A.K.; Arteaga, C.L. p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. J. Cell Sci. 2002, 115, 3193–3206. [Google Scholar] [PubMed]
- Sari, Z.; Miko, E.; Kovacs, T.; Janko, L.; Csonka, T.; Lente, G.; Sebo, E.; Toth, J.; Toth, D.; Arkosy, P.; et al. Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress. Cancers 2020, 12, 2411. [Google Scholar] [CrossRef] [PubMed]
- Esposito, G.; Gigli, S.; Seguella, L.; Nobile, N.; D’Alessandro, A.; Pesce, M.; Capoccia, E.; Steardo, L.; Cirillo, C.; Cuomo, R.; et al. Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway. Int. J. Oncol. 2016, 49, 639–645. [Google Scholar] [CrossRef] [Green Version]
- Hanahan, D.; Weinberg, R.A. Hallmarks of Cancer: The Next Generation. Cell 2011, 144, 646–674. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shacter, E.; Weitzman, S.A. Chronic inflammation and cancer. Oncol. (Williston Park) 2002, 16, 217–232. [Google Scholar]
- Colotta, F.; Allavena, P.; Sica, A.; Garlanda, C.; Mantovani, A. Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 2009, 30, 1073–1081. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Morgan, E.T.; Goralski, K.B.; Piquette-Miller, M.; Renton, K.W.; Robertson, G.R.; Chaluvadi, M.R.; Charles, K.A.; Clarke, S.J.; Kacevska, M.; Liddle, C.; et al. Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer. Drug Metab. Dispos. 2008, 36, 205–216. [Google Scholar] [CrossRef] [Green Version]
- Robertson, G.R.; Liddle, C.; Clarke, S.J. Inflammation and Altered Drug Clearance in Cancer: Transcriptional Repression of a Human CYP3A4 Transgene in Tumor-bearing Mice. Clin. Pharmacol. Ther. 2008, 83, 894–897. [Google Scholar] [CrossRef] [PubMed]
- Zhou, C.; Tabb, M.M.; Nelson, E.L.; Grun, F.; Verma, S.; Sadatrafiei, A.; Lin, M.; Mallick, S.; Forman, B.M.; Thummel, K.E.; et al. Mutual repression between steroid and xenobiotic receptor and NF-κB signaling pathways links xenobiotic metabolism and inflammation. J. Clin. Investig. 2006, 116, 2280–2289. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sun, M.; Cui, W.; Woody, S.K.; Staudinger, J.L. Pregnane X Receptor Modulates the Inflammatory Response in Primary Cultures of Hepatocytes. Drug Metab. Dispos. 2015, 43, 335–343. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Slaviero, K.A.; Clarke, S.J.; Rivory, L.P. Inflammatory response: An unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. Lancet Oncol. 2003, 4, 224–232. [Google Scholar] [CrossRef]
- Inui, A. Cancer anorexia-cachexia syndrome: Current issues in research and management. CA Cancer J. Clin. 2002, 52, 72–91. [Google Scholar] [CrossRef]
- Gu, X.; Ke, S.; Liu, D.; Sheng, T.; Thomas, P.E.; Rabson, A.B.; Gallo, M.A.; Xie, W.; Tian, Y. Role of NF-kappaB in regulation of PXR-mediated gene expression: A mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J. Biol. Chem. 2006, 281, 17882–17889. [Google Scholar] [CrossRef] [Green Version]
- Langmann, T.; Moehle, C.; Mauerer, R.; Scharl, M.; Liebisch, G.; Zahn, A.; Stremmel, W.; Schmitz, G. Loss of Detoxification in Inflammatory Bowel Disease: Dysregulation of Pregnane X Receptor Target Genes. Gastroenterology 2004, 127, 26–40. [Google Scholar] [CrossRef]
- Dring, M.M.; Goulding, C.A.; Trimble, V.I.; Keegan, D.; Ryan, A.W.; Brophy, K.M.; Smyth, C.M.; Keeling, P.W.N.; O’Donoghue, D.; O’Sullivan, M.; et al. The Pregnane X Receptor Locus Is Associated With Susceptibility to Inflammatory Bowel Disease. Gastroenterology 2006, 130, 341–348. [Google Scholar] [CrossRef]
- Wen, J.; Lv, Z.; Ding, H.; Fang, X.; Sun, M. Association between PXR polymorphisms and cancer risk: A systematic review and meta-analysis. Biosci. Rep. 2018, 38, BSR20171614. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sandanaraj, E.; Lal, S.; Selvarajan, V.; Ooi, L.L.; Wong, Z.W.; Wong, N.S.; Ang, P.C.; Lee, E.J.; Chowbay, B. PXR pharmacogenetics: Association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients. Clin. Cancer Res. 2008, 14, 7116–7126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schipani, A.; Siccardi, M.; D’Avolio, A.; Baietto, L.; Simiele, M.; Bonora, S.; Novoa, S.R.; Cuenca, L.; Soriano, V.; Chierakul, N.; et al. Population pharmacokinetic modeling of the association between 63396C→T pregnane X receptor polymorphism and unboosted atazanavir clearance. Antimicrob. Agents Chemother. 2010, 54, 5242–5250. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Justenhoven, C.; Schaeffeler, E.; Winter, S.; Baisch, C.; Hamann, U.; Harth, V.; Rabstein, S.; Spickenheuer, A.; Pesch, B.; Bruning, T.; et al. Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk. Breast Cancer Res. Treat. 2011, 125, 563–569. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Abbas, S.; Beckmann, L.; Changclaude, J.; Hein, R.; Kropp, S.; Parthimos, M.; Dunnebier, T.; Hamann, U.; Brors, B.; Eils, R. MARIE-GENICA Consortium on genetic susceptibility for menopausal hormone therapy related breast cancer risk polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women. Breast Cancer Res. Treat. 2010, 120, 727–736. [Google Scholar] [CrossRef]
- Liu, C.L.; Lim, Y.P.; Hu, M.L. Fucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cells. Mar. Drugs 2012, 10, 242–257. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Heinlein, C.A.; Chang, C. Androgen receptor in prostate cancer. Endocr. Rev. 2004, 25, 276–308. [Google Scholar] [CrossRef] [Green Version]
- Kono, M.; Fujii, T.; Lim, B.; Karuturi, M.S.; Tripathy, D.; Ueno, N.T. Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer: A Review. JAMA Oncol. 2017, 3, 1266–1273. [Google Scholar] [CrossRef]
- Lin, M.-L.; Patel, H.; Remenyi, J.; Banerji, C.R.S.; Lai, C.-F.; Periyasamy, M.; Lombardo, Y.; Busonero, C.; Ottaviani, S.; Passey, A.; et al. Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer. Oncotarget 2015, 6, 21685–21703. [Google Scholar] [CrossRef] [Green Version]
- Garg, A.; Zhao, A.; Erickson, S.L.; Mukherjee, S.; Lau, A.J.; Alston, L.; Chang, T.K.; Mani, S.; Hirota, S.A. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation. J. Pharmacol. Exp. Ther. 2016, 359, 91–101. [Google Scholar] [CrossRef] [Green Version]
- Hudson, G.; Flannigan, K.L.; Venu, V.K.P.; Alston, L.; Sandall, C.F.; MacDonald, J.A.; Muruve, D.A.; Chang, T.K.H.; Mani, S.; Hirota, S.A. Pregnane X Receptor Activation Triggers Rapid ATP Release in Primed Macrophages That Mediates NLRP3 Inflammasome Activation. J. Pharmacol. Exp. Ther. 2019, 370, 44–53. [Google Scholar] [CrossRef] [PubMed]
- Wang, S.; Lei, T.; Zhang, K.; Zhao, W.; Fang, L.; Lai, B.; Han, J.; Xiao, L.; Wang, N. Xenobiotic pregnane X receptor (PXR) regulates innate immunity via activation of NLRP3 inflammasome in vascular endothelial cells. J. Biol. Chem. 2014, 289, 30075–30081. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, S.; Xie, X.; Lei, T.; Zhang, K.; Lai, B.; Zhang, Z.; Guan, Y.; Mao, G.; Xiao, L.; Wang, N. Statins Attenuate Activation of the NLRP3 Inflammasome by Oxidized LDL or TNFalpha in Vascular Endothelial Cells through a PXR-Dependent Mechanism. Mol. Pharmacol. 2017, 92, 256–264. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cheng, J.; Fang, Z.Z.; Nagaoka, K.; Okamoto, M.; Qu, A.; Tanaka, N.; Kimura, S.; Gonzalez, F.J. Activation of intestinal human pregnane X receptor protects against azoxymethane/dextran sulfate sodium-induced colon cancer. J. Pharmacol. Exp. Ther. 2014, 351, 559–567. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Creamer, B.A.; Sloan, S.N.B.; Dennis, J.F.; Rogers, R.; Spencer, S.; McCuen, A.; Persaud, P.; Staudinger, J.L. Associations between Pregnane X Receptor and Breast Cancer Growth and Progression. Cells 2020, 9, 2295. https://doi.org/10.3390/cells9102295
Creamer BA, Sloan SNB, Dennis JF, Rogers R, Spencer S, McCuen A, Persaud P, Staudinger JL. Associations between Pregnane X Receptor and Breast Cancer Growth and Progression. Cells. 2020; 9(10):2295. https://doi.org/10.3390/cells9102295
Chicago/Turabian StyleCreamer, Bradley A., Shelly N. B. Sloan, Jennifer F. Dennis, Robert Rogers, Sidney Spencer, Andrew McCuen, Purnadeo Persaud, and Jeff L. Staudinger. 2020. "Associations between Pregnane X Receptor and Breast Cancer Growth and Progression" Cells 9, no. 10: 2295. https://doi.org/10.3390/cells9102295